1-4 of 4
Masaru Shibata
Close
Sort by
Journal Articles

A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3 + T regulatory cells

Hideto Matsui, Masaru Shibata, Brian Brown, Andrea Labelle, Carol Hegadorn, Chandler Andrews, Marinee Chuah, Thierry VandenDriessche, Carol H. Miao, Christine Hough, David Lillicrap
Journal: Blood
Blood (2009) 114 (3): 677–685.
https://doi.org/10.1182/blood-2009-03-202267
Published: 2009
Journal Articles

Ex Vivo Gene Trasfer for Hemophilia A That Enhances Safety and Results in Sustained In Vivo Factor VIII Expression from Lentivirally-Engineered Endothelial Progenitors.

Hideto Matsui, MD, PhD, Masaru Shibata, MD/PhD, Brian Brown, PhD, Andrea Labelle, Carol Hegadorn, Chandler Andrews, Robert P. Hebbel, MD, Jacques Galipeau, MD, Christine Hough, PhD, David Lillicrap, MD
Journal: Blood
Blood (2006) 108 (11): 3251.
https://doi.org/10.1182/blood.V108.11.3251.3251
Published: 2006
Journal Articles

A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C–catalyzed inactivation

Keiji Nogami, Midori Shima, Katsumi Nishiya, Kazuya Hosokawa, Evgueni L. Saenko, Yoshihiko Sakurai, Masaru Shibata, Hiroshi Suzuki, Ichiro Tanaka, Akira Yoshioka
Journal: Blood
Blood (2002) 99 (11): 3993–3998.
https://doi.org/10.1182/blood.V99.11.3993
Published: 2002
Journal Articles

Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C–mediated proteolysis

Keiji Nogami, Midori Shima, John C. Giddings, Kazuya Hosokawa, Masanori Nagata, Seiki Kamisue, Hiroshi Suzuki, Masaru Shibata, Evgueni L. Saenko, Ichiro Tanaka, Akira Yoshioka
Journal: Blood
Blood (2001) 97 (3): 669–677.
https://doi.org/10.1182/blood.V97.3.669
Published: 2001